A carregar...
Similar safety and efficacy in previously treated adults with growth hormone deficiency randomized to once‐weekly somapacitan or daily growth hormone
OBJECTIVE: Somapacitan is a long‐acting, reversible albumin‐binding growth hormone (GH) derivative in development. This study aimed to evaluate the safety and efficacy of once‐weekly somapacitan versus daily GH over 52 weeks in Japanese patients with adult growth hormone deficiency (AGHD). DESIGN: P...
Na minha lista:
| Publicado no: | Clin Endocrinol (Oxf) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7689735/ https://ncbi.nlm.nih.gov/pubmed/32603494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.14273 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|